SGLT2 inhibitors: an evidence-based update on cardiovascular implications.
Forzano I, Wilson S, Lombardi A, Jankauskas SS, Kansakar U, Mone P, Varzideh F, Santulli G.
Forzano I, et al. Among authors: lombardi a.
Expert Opin Investig Drugs. 2023 Jul-Dec;32(9):839-847. doi: 10.1080/13543784.2023.2263354. Epub 2023 Oct 13.
Expert Opin Investig Drugs. 2023.
PMID: 37740906
Free PMC article.
Review.